Genocea Provides Fourth Quarter 2019 Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Strong Panama quake shakes nation, but avoids major destruction
- SpaceX to acquire Grain Management's 800 MHz spectrum portfolio
- CoreWeave stock drops on dilution fears and debt concerns
Genocea Biosciences (GNCA) Tops Q4 EPS by 5c
February 13, 2020 7:19 AM ESTGenocea Biosciences (NASDAQ: GNCA) reported Q4 EPS of ($0.34), $0.05 better than the analyst estimate of ($0.39).
Genocea made critical scientific and clinical progress in the last quarter, said Chip Clark, President and Chief Executive Officer, Genocea. The discovery and understanding of inhibigens has the potential to... More



